Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Identification of a novel biomarker signature associated with risk for bone metastasis in patients with renal cell carcinoma.

The International journal of biological markers - 1 Jan 2000

Paule Bernard, Deslandes Emmanuelle, Le Mouel St Phane E, Bastien Laurence, Podgorniak Marie-Pierre, Allory Yves, de la Taille Alexandre, Menashi Suzanne, Calvo Fabien, Mourah Samia

Abstract excerpt

When renal cell carcinoma (RCC) metastasizes to bone (a frequent site of systemic spread of this cancer) it becomes highly resistant to radiation therapy and chemotherapy. A better understanding of the biology of bone metastasis in RCC may permit to identify biomarkers for early detection of subc...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Biomarkers, Tumor

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Bone Neoplasms

Share to Carcinoma, Renal Cell

Share to Gene Expression Profiling

Share to Gene Expression Regulation, Neoplastic

Share to Kidney Neoplasms

Share to Risk Factors

Source

Identifiers

PMID: 20544684
DOI: 10.1177/172460081002500209

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-20544684-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Identification of a novel biomarker signature associated with risk for bone metastasis in patients with renal cell carcinoma.PMID 20544684Read ↗

Biomarker-Driven Approaches to Bone Metastases: From Molecular Mechanisms to Clinical ApplicationsSemantic proximity Read ↗

Molecular biomarkers in advanced renal cell carcinoma.Semantic proximity Read ↗

Tumour-derived miRNAs and bone metastasisSemantic proximity Read ↗

Gene signatures of pulmonary metastases of renal cell carcinoma reflect the disease‐free interval and the number of metastases per patientSemantic proximity Read ↗

Gene Signatures of Progression and Metastasis in Renal Cell CancerSemantic proximity Read ↗

CD31, EDNRB and TSPAN7 are promising prognostic markers in clear‐cell renal cell carcinoma revealed by genome‐wide expression analyses of primary tumors and metastasesSemantic proximity Read ↗

Heterogeneous drug target expression as possible basis for different clinical and radiological response to the treatment of primary and metastatic renal cell carcinoma: suggestions from bench to bedside.Semantic proximity Read ↗

Vascular cell adhesion molecule 1 predicts cancer-free survival in clear cell renal carcinoma patients.Semantic proximity Read ↗

Genomics and proteomics of bone cancer.Semantic proximity Read ↗

Identification of a Plasma Four-microRNA Panel as Potential Noninvasive Biomarker for OsteosarcomaSemantic proximity Read ↗

A bone-seeking clone exhibits different biological properties from the ACHN parental human renal cell carcinoma in vivo and in vitro.Semantic proximity Read ↗

Blockade of the vascular endothelial growth factor-receptor 2 pathway inhibits the growth of human renal cell carcinoma, RBM1-IT4, in the kidney but not in the bone of nude mice.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.